Abstract
Giant Cell Arteritis (GCA), also known as Temporal Arteritis, is a type of large vessel vasculitis primarily affecting the elderly population. It typically manifests with headaches, visual impairment, and jaw claudication. Although third nerve palsy as the primary presentation of GCA is rare, it has been reported in previous instances. In this report, we describe the case of a patient presenting with pupil-sparing third nerve palsy, ultimately diagnosed with GCA, and successfully managed with steroids and tocilizumab. A lady in her 80s with past medical history of well-controlled hypertension, bladder cancer in remission, a twenty-pack year smoking history, cervical and lumbar spine stenosis, and recent immunizations presented with acute onset of right-sided pupil-sparing third nerve palsy. Labs were pertinent for an elevated ESR and CRP. Brain imaging was without acute abnormalities. A temporal artery biopsy established evidence of healed arteritis and a diagnosis of GCA was made. The patient was treated with pulse-dose steroids followed by an oral steroid taper and tocilizumab. At one month follow-up, there was partial resolution in her ophthalmoplegia. We underscore the importance of considering temporal arteritis as a potential cause of third nerve palsy in the elderly before attributing it solely to microvascular ischemia, particularly in patients with constitutional features. Additionally, in our comprehensive literature review, we aim to consolidate the existing data from similar presentations, shedding light on the clinical manifestation and disease trajectory.
Similar content being viewed by others
Data availability
All datasets for this review are included in the manuscript and the supplementary files.
References
Burg LC, Karakostas P, Behning C, Brossart P, Kermani TA, Schäfer VS (2023) Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study. Therapeutic Adv Musculoskelet Disease 15:1759720X2211499. https://doi.org/10.1177/1759720x221149963
Mehler MF, Rabinowich L (1988) The clinical neuro-ophthalmologic spectrum of temporal arteritis. Am J Med 85(6):839–844. https://doi.org/10.1016/S0002-9343(88)80031-7
Lazaridis C, Torabi A, Cannon S (2005) Bilateral third nerve palsy and temporal arteritis. Arch Neurol 62(11):1766. https://doi.org/10.1001/archneur.62.11.1766
Li KJ, Semenov D, Turk M, Pope J (2021) A meta-analysis of the epidemiology of giant cell arteritis across time and space. Arthritis Res Therapy 23(1). https://doi.org/10.1186/s13075-021-02450-w
Vaccari F, Baldini E (1959) [A case of temporal arthritis: Horton-Magath-Brown syndrome]. Minerva Med 50(7):169–174
Fytili C, Bournia VK, Korkou C, Pentazos G, Kokkinos A (2015) Multiple cranial nerve palsies in giant cell arteritis and response to cyclophosphamide: a case report and review of the literature. Rheumatol Int 35(4):773–776. https://doi.org/10.1007/s00296-014-3126-8
Meadows SP (1966) Temporal or giant cell arteritis. Proc R Soc Med 59(4):329–334
Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Care Res 55(6):985–989. https://doi.org/10.1002/art.22359
Cardell BS, Hanley T (1951) A fatal case of giant-cell or temporal arteritis. J Pathol Bacteriol 63(4):587–597. https://doi.org/10.1002/path.1700630405
Ostberg G (1972) Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand Suppl 533:135–159
Thurtell MJ, Longmuir RA (2014) Third nerve palsy as the initial manifestation of giant cell arteritis. J Neuroophthalmol 34(3):243–245. https://doi.org/10.1097/WNO.0000000000000116
Walters B, Lazic D, Ahmed A, Yiin G (2020) Lessons of the month 4: giant cell arteritis with normal inflammatory markers and isolated oculomotor nerve palsy. Clin Med (Lond) 20(2):224–226. https://doi.org/10.7861/clinmed.2019-0504
Day AMN (2006) Giant cell arteritis presenting as painful third nerve palsy. Br J Hosp Med (Lond) 67(7):383
Adolfo DCA, Francisca MS, Roberto MZ, Luis CR (2018) Arteritis De células gigantes en El Sistema Vertebrobasilar, isquemias cerebelo-occipitales y parálisis III par. Caso clínico. Revista médica De Chile 146(11):1356–1360. https://doi.org/10.4067/s0034-98872018001101356
Asensio-Sánchez VM, Morales-Gómez I, Rodríguez-Vaca I (2009) Parálisis Del tercer par craneal como única manifestación de arteritis de la temporal oculta. Arch De La Sociedad Española De Oftalmología 84(8). https://doi.org/10.4321/s0365-66912009000800005
Miscioscia A, Decet P, Angelini A, Cecchin D, Cagnin A (2022) Complex oculomotor nerves palsy and incidental ischemic stroke as atypical presentation of giant cell arteritis. Neurol Sci 43(6):4011–4013. https://doi.org/10.1007/s10072-022-05993-1
Oncel C, Bir F, Bir LS (2007) Simultaneous ischemic optic neuropathy and third cranial nerve palsy in giant cell arteritis. J Neuroophthalmol 27(4):315–316. https://doi.org/10.1097/WNO.0b013e31815c441e
Loffredo L, Parrotto S, Violi F (2004) Giant cell arteritis, oculomotor nerve palsy, and acute hearing loss. Scand J Rheumatol 33(4):279–280. https://doi.org/10.1080/03009740410006178
Maghera S, Albreiki D (2018) A case of Hickam’s dictum in a presenting third nerve palsy. Can J Ophthalmol 53(4):e140–e142. https://doi.org/10.1016/j.jcjo.2017.10.031
Hiraoka D, Ishizaki J, Horie K, Matsumoto T, Suemori K, Takenaka K, Hasegawa H (2021) Giant cell arteritis presenting with ptosis and Diplopia. Intern Med 60(14):2333–2336. https://doi.org/10.2169/internalmedicine.6521-20
Gaudre N, Michaud M, Soler V, Lozano S, Gaudin C, Balardy L (2015) Giant cell arteritis: a reversible cause of oculomotor nerve palsy. Presse Med 44(7–8):859–860. https://doi.org/10.1016/j.lpm.2015.03.013
Martis A, Hassan RS, Alburquerque AG, Kotte M, Martis A, Ahmed H (2020) An interesting case of temporal arteritis that manifested as ptosis and diplopia. Oxf Med Case Rep 2020(11). https://doi.org/10.1093/omcr/omaa099
Bondeson J, Åsman P (1997) Giant cell arteritis presenting with Oculomotor nerve Palsy. Scand J Rheumatol 26(4):327–328. https://doi.org/10.3109/03009749709105324
Ng WL, McManus J, Devlin JA, Fraser A (2016) Unmasking the elusive giant: an unusual case presenting as third nerve palsy in a patient with scleroderma. BMJ Case Rep. https://doi.org/10.1136/bcr-2016-214633. 2016:101136/bcr-2016-214633
Örnek N, Dağ E, Büyüktortop N, Oğurel R, Örnek K (2013) Bilateral recurrent Optic Neuropathy with Unilateral Oculomotor nerve Palsy in Giant Cell Arteritis. Ocul Immunol Inflamm 21(2):158–159. https://doi.org/10.3109/09273948.2012.747620
Ross M, Bursztyn L, Superstein R, Gans M (2017) Multiple cranial nerve palsies in Giant Cell Arteritis. J Neuroophthalmol 37(4):398–400. https://doi.org/10.1097/WNO.0000000000000529
Davies GE, Shakir RA (1994) Giant cell arteritis presenting as oculomotor nerve palsy with pupillary dilatation. Postgrad Med J 70(822):298–299. https://doi.org/10.1136/pgmj.70.822.298
Polak P, Pokorny V, Stvrtina S, Tauchmannova H, Malis F, Rovensky J (2005) Temporal arteritis presenting with paresis of the oculomotor nerve, and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate. J Clin Rheumatol 11(4):242–244. https://doi.org/10.1097/01.rhu.0000173621.55149.d6
Anijeet DRS, Graham C, Khooshabeh R (2006) Giant cell arteritis—part of a spectrum of autoimmune disease? Eye 20(12):1434–1435. https://doi.org/10.1038/sj.eye.6702294
Bravi P, Tolaini P (2012) Ptosi palpebrale con diplopia da paralisi del terzo nervo cranico e tumefazione orbitaria: manifestazioni inusuali in Un caso di arterite a cellule giganti associata a polimialgia reumatica. Italian J Med 6(4):343–346. https://doi.org/10.1016/j.itjm.2011.12.001
Chazal T, Clavel G, Leturcq T, Philibert M, Lecler A, Vignal-Clermont C (2023) Characteristics and prognosis of Binocular Diplopia in patients with Giant Cell Arteritis. J Neuroophthalmol. https://doi.org/10.1097/WNO.0000000000001912
Lee YC, Padera RF, Noss EH, Fossel AH, Bienfang D, Liang MH, Docken WP (2012) Clinical course and management of a consecutive series of patients with healed temporal arteritis. J Rhuematol 39(2):295–302. https://doi.org/10.3899/jrheum.110317
Sun E, Li X, Gruener AM, Chang JR, Eberhart CG, Henderson AD, Carey AR (2023) Presenting features of giant cell arteritis with active Versus healed Arteritis on Biopsy. Neuroophthalmology 47(3):129–135. https://doi.org/10.1080/01658107.2023.2175874
Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, Butikofer L, Seitz M, Reichenbach S (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387(10031):1921–1927. https://doi.org/10.1016/S0140-6736(16)00560-2
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N (2017) Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med 377(4):317–328. https://doi.org/10.1056/nejmoa1613849
Yoshimoto K, Kaneda S, Asada M, Taguchi H, Kawashima H, Yoneima R, Matsuoka H, Tsushima E, Ono S, Matsubara M, Yada N, Nishio K (2023) Giant cell arteritis after COVID-19 vaccination with Long-Term Follow-Up: a Case Report and Review of the literature. Medicina 59(12):2127. https://doi.org/10.3390/medicina59122127
Wakabayashi H, Iwayanagi M, Sakai D, Sugiura Y, Hiruta N, Matsuzawa Y, Kaneko K (2023) Development of giant cell arteritis after vaccination against SARS-CoV2: a case report and literature review. Med (Baltim) 102(22):e33948. https://doi.org/10.1097/MD.0000000000033948
Soriano A, Verrecchia E, Marinaro A, Giovinale M, Fonnesu C, Landolfi R, Manna R (2012) Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 21(2):153–157. https://doi.org/10.1177/0961203311430222
Acknowledgements
We acknowledge the contributions of all medical professionals involved researchers whose publications helped us come up with this review. We also acknowledge the kindness of the patients and their families who are helping to disseminating medical knowledge. We are grateful for our institutions who supported this work through resources and facilities.
Author information
Authors and Affiliations
Contributions
Conception or design of the work: AA, KM. Acquisition, analysis, or interpretation of data for the work: AA, KM, FT. Drafting the work or revising it critically for important intellectual content: AA, KM, AW. Final approval of the version to be published: AA, KM, FT, AW. All authors take full responsibility for the integrity and accuracy of all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that might influence the data reported in this paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arya PV, A., Madathanapalli, K.A., Tenezaca, F.C. et al. Temporal arteritis presenting as third nerve palsy - a case report and review of literature. Rheumatol Int (2024). https://doi.org/10.1007/s00296-024-05604-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00296-024-05604-6